Venture Life Group (LON:VLG) Share Price Crosses Below 50 Day Moving Average – Here’s What Happened

Venture Life Group plc (LON:VLG)’s stock price crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of GBX 67.59 and traded as low as GBX 67.40. Venture Life Group shares last traded at GBX 67.60, with a volume of 489,789 shares changing hands.

Venture Life Group Price Performance

The company has a current ratio of 4.71, a quick ratio of 1.48 and a debt-to-equity ratio of 0.82. The stock has a fifty day simple moving average of GBX 67.48 and a 200-day simple moving average of GBX 65.11. The stock has a market cap of £79.00 million, a price-to-earnings ratio of 15.06, a price-to-earnings-growth ratio of 5.67 and a beta of 0.23.

Venture Life Group (LON:VLG) last issued its quarterly earnings results on Tuesday, September 29th. The company reported GBX 4.10 EPS for the quarter. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%. As a group, equities research analysts expect that Venture Life Group plc will post 6.1391542 EPS for the current year.

Insiders Place Their Bets

In related news, insider Daniel Wells purchased 38,717 shares of Venture Life Group stock in a transaction on Wednesday, September 30th. The stock was purchased at an average cost of GBX 65 per share, with a total value of £25,166.05. 7.52% of the stock is currently owned by company insiders.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.